Patients Confused, Concerned About Diagnosis, Treatment of DCIS
TUESDAY, Feb. 22, 2022 -- Patients with ductal carcinoma in situ (DCIS) report confusion and concern about diagnosis and treatment, according to a study published online Feb. 22 in Cancer.
Shoshana M. Rosenberg, Sc.D., M.P.H., from the Dana-Farber...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Carcinoma in Situ | DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | Pharmaceuticals | Study